20 April 2026
Advanced Medical Solutions Group plc(“AMS” or the “Company”) Statement regarding possible offer The Board of AMS notes the recent press speculation and confirms it is…
Upgrade to FY2026 guidance Since our H1 results announcement on 11 February, we have seen particularly strong demand from customers in the semiconductor and…
16 April 2026
B.P. Marsh & Partners Plc (“B.P. Marsh”, “the Company” or “the Group”) Receipt of Deferred Consideration Following Sale and Intention to Declare a Special…
13 April 2026
Concurrent Technologies Plc (the “Company” or the “Group”) Final results for the year ended 31 December 2025 Double digit growth with a record order…
10 April 2026
LONDON STOCK EXCHANGE ANNOUNCEMENT THE MERCANTILE INVESTMENT TRUST PLC FINAL RESULTS FOR THE YEAR ENDED 31ST JANUARY 2026 Legal Entity Identifier: 549300BGX3CJIHLP2H42 Information disclosed in…
8 April 2026
Board Changes Renishaw plc (“Company”), a leading provider of manufacturing technologies, analytical instruments and medical devices, announces the following changes to its Board of…
Exdensur (depemokimab) approved in China for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) GSK plc (LSE/NYSE: GSK) today announced that China’s National Medical…
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s”) Young’s to acquire Cubitt House Young’s, the premium operator of pubs and bedrooms in London and the South…